Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (131-140 of 270) with videos related to

Pageof 27
Sort By:
Cancer Research|June 12, 2020
p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate CancerSonghui Xu, Lingling Fan, Hee-Young Jeon, et al.
Scientific Reports|September 14, 2016
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33Iryna Saranchova, Jeffrey Han, Hui Huang, et al.
European Urology Focus|May 8, 2021
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder CancerMoritz Maas, Steffen Rausch, Teresa Guttenberg, et al.
Sensing and Bio-Sensing Research|July 22, 2016
Real-time and label free determination of ligand binding-kinetics to primary cancer tissue specimens; a novel tool for the assessment of biomarker targetingThomas Mandel Clausen, Marina Ayres Pereira, Htoo Zarni Oo, et al.
Oncotarget|May 17, 2018
20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumorsMohamed Ben-Eltriki, Subrata Deb, Mohamed Hassona, et al.
Frontiers in Immunology|March 25, 2024
A novel type-2 innate lymphoid cell-based immunotherapy for cancerIryna Saranchova, Clara Wenjing Xia, Stephanie Besoiu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 6, 2021
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranosticsClaudia Kesch, Leubet Yirga, Katharina Dendl, et al.
Molecular Endocrinology (Baltimore, Md.)|June 30, 2012
Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancerKaijie Wu, Crystal Gore, Lin Yang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 24, 2015
A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in miceH Bobby Fokidis, Mei Yieng Chin, Victor W Ho, et al.
Plos One|April 5, 2013
Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approachWolfgang Jäger, Igor Moskalev, Claudia Janssen, et al.
Pageof 27

Showing results (131-140 of 270) with videos related to

Sort By:
Pageof 27
Cancer Research|June 12, 2020
p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate CancerSonghui Xu, Lingling Fan, Hee-Young Jeon, et al.
Scientific Reports|September 14, 2016
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33Iryna Saranchova, Jeffrey Han, Hui Huang, et al.
European Urology Focus|May 8, 2021
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder CancerMoritz Maas, Steffen Rausch, Teresa Guttenberg, et al.
Sensing and Bio-Sensing Research|July 22, 2016
Real-time and label free determination of ligand binding-kinetics to primary cancer tissue specimens; a novel tool for the assessment of biomarker targetingThomas Mandel Clausen, Marina Ayres Pereira, Htoo Zarni Oo, et al.
Oncotarget|May 17, 2018
20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumorsMohamed Ben-Eltriki, Subrata Deb, Mohamed Hassona, et al.
Frontiers in Immunology|March 25, 2024
A novel type-2 innate lymphoid cell-based immunotherapy for cancerIryna Saranchova, Clara Wenjing Xia, Stephanie Besoiu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 6, 2021
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranosticsClaudia Kesch, Leubet Yirga, Katharina Dendl, et al.
Molecular Endocrinology (Baltimore, Md.)|June 30, 2012
Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancerKaijie Wu, Crystal Gore, Lin Yang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 24, 2015
A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in miceH Bobby Fokidis, Mei Yieng Chin, Victor W Ho, et al.
Plos One|April 5, 2013
Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approachWolfgang Jäger, Igor Moskalev, Claudia Janssen, et al.
Pageof 27